Alopecia Areata linked to Increased Risk of Celiac Disease, reports study Dr Riya Dave1 Dec 2024 8:30 PM ISTResearchers have found that alopecia areata (AA) (an autoimmune disease leading to hair loss), increases patients chances of developing celiac...
Low-dose oral minoxidil initiation for patients with hair loss: International modified Delphi consensus statement Dr. Kamal Kant Kohli22 Nov 2024 7:00 AM ISTHair loss significantly impacts patients' quality of life, and it may be nonscarring or scarring. Etiologically, hair loss may be hereditary...
Sun Pharma alopecia drug Leqselvi launch blocked in US Farhat Nasim4 Nov 2024 7:05 PM ISTNew Delhi: Pharma giant, Sun Pharmaceutical's launch of its specialty drug Leqselvi in the U.S. market is in limbo as the U.S. District Court in...
Topical corticosteroids treatment under occlusion effective in pediatric patients with severe Alopecia Areata: Study Jacinthlyn Sylvia1 Nov 2024 8:00 PM ISTA new study published in the journal of Clinical and Experimental Dermatology showed that a strong topical corticosteroid (TCS) occlusion may be...
Sun Pharma presents Leqselvi data highlighting clinical efficacy, durability for Alopecia Areata treatment at 2024 Fall Clinical Dermatology Conference Ruchika Sharma28 Oct 2024 11:30 AM ISTMumbai: Sun Pharmaceutical Industries Limited has presented new data highlighting the clinical efficacy and safety of LEQSELVI (deuruxolitinib) 8...
Tick Bite Triggers Unusual Alopecia Areata-Like Hair Loss in 28-Year-Old Woman: Case Report Medha Baranwal26 Oct 2024 1:00 AM ISTUSA: A recent case report published in JAAD Case Reports has brought renewed attention to alopecia following tick bites, a rare but intriguing...
Twice-Daily Deuruxolitinib Significantly Improves Alopecia Areata Over 24 Weeks: Study Dr Riya Dave11 Oct 2024 8:00 PM ISTResearchers found that twice-daily deuruxolitinib (Leqselvi), at an 8 mg dose, significantly improved hair satisfaction of patients with severe...
Active ritlecitinib may improve hair growth in patients with alopecia areata: Study Jacinthlyn Sylvia7 Oct 2024 8:00 PM ISTA new study published in the journal of Dermatology suggests that the Alopecia areata patients who were receiving doses of active ritlecitinib...
Sun Pharma presents new clinical efficacy, safety data in severe dermatological conditions at 2024 EADV Congress Ruchika Sharma27 Sept 2024 3:51 PM ISTMumbai: Sun Pharmaceutical Industries Limited has announced that it will present abstracts across its dermatology portfolio at the 33rd European...
Study Confirms Baricitinib's Effectiveness for Severe Alopecia Areata and Advocates for Early Trichoscopy Medha Baranwal17 Sept 2024 9:45 PM ISTItaly: A recent 24-week study conducted in Italy has yielded promising results regarding the effectiveness and safety of baricitinib for patients with...
Eli Lilly, EVA Pharma collaborate to expand access to baricitinib in low- to middle-income countries Ruchika Sharma8 Sept 2024 10:00 AM ISTIndianapolis: Eli Lilly and Company and EVA Pharma have announced that the companies have entered into an agreement to expand access to...
Obese children more likely to develop skin conditions related to the immune system, suggests study Dr. Kamal Kant Kohli23 Aug 2024 9:15 AM ISTChildhood obesity can contribute to the development of common immune-mediated skin diseases (IMSDs), such as alopecia areata, atopic dermatitis, and...
